Aptus Capital Advisors »

Milestone Pharmaceuticals shares owned by Aptus Capital Advisors

Quarter-by-quarter ownership of Milestone Pharmaceuticals (MIST) shares owned by Aptus Capital Advisors from 13F filings

Historical chart of Aptus Capital Advisors investment in Milestone Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Milestone Pharmaceuticals held by Aptus Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Milestone Pharmaceuticals by Aptus Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $420k 210k 2.00

More positions owned by Aptus Capital Advisors

Ishares Tr Iboxx Hi Yd Etf (HYG)
Etf Ser Solutions Aptus Collrd Inv (ACIO)
Doordash Cl A (DASH)
Etf Ser Solutions Aptus Defined (DRSK)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
Microsoft Corporation Put Option (MSFT)
salesforce (CRM)
Tesla Motors (TSLA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Eli Lilly & Co. (LLY)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Exch Trd Slf Idx Bulletshs 2032 (BSCW)

View all positions for Aptus Capital Advisors

Top funds holding Milestone Pharmaceuticals

Adage Capital Partners GP
Propel Bio Management
OrbiMed Advisors
Simplify Asset Management
Rtw Investments
Pathstone Holdings
Morgan Stanley
Sphera Funds Management
Toronto-Dominion Bank
Affinity Asset Advisors
Boxer Capital Management
Two Sigma Investments
Lion Point Capital
Citadel Advisors
Susquehanna International

View all funds holding Milestone Pharmaceuticals